Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568905 · ClinicalTrials.gov registry record · NA
Palatability of Experimental Cigarettes - Study 2
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT01568905 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 36 participants.
The verdict
NCT01568905, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
Smoking remains a leading cause of preventable disease and premature death worldwide. Approximately 1 out of every 5 deaths is associated with cigarette smoking, and roughly half of all daily smokers will die prematurely from tobacco-related illness. Reducing the nicotine in cigarettes to the point that they are rendered non-addictive can potentially be an effective public policy measure that can significantly reduce tobacco-related mortality and morbidity by decreasing the initiation of smoking and promoting cessation. The Family Smoking Prevention and Tobacco Control Act (FSPTCA) enables the FDA to establish tobacco product standards including placing limits on the allowable nicotine content of cigarettes. Currently, no reduced nicotine cigarettes are available that will allow studying the feasibility of this policy measure. The National Institute on Drug Abuse has contracted with Research Triangle Institute to assist in the development of cigarettes with varying nicotine content that can be made available to researchers. They have established a contract that will result in the manufacture of 9 million cigarettes to be distributed to the research community. Prior to full production, the palatability and nicotine intake of these cigarettes in smokers must be determined.
Interventions
- OTHER Low level nicotine cigarette
- OTHER Intermediate nicotine level cigarette
- OTHER High level nicotine cigarette
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01568905
The ClinicalTrials.gov registry entry for NCT01568905 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Low level nicotine cigarette is the first listed.
NCT01568905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01568905 about?
NCT01568905 is a clinical study titled "Palatability of Experimental Cigarettes - Study 2". Smoking remains a leading cause of preventable disease and premature death worldwide. Approximately 1 out of every 5 deaths is associated with cigarette smoking, and roughly half of all daily smokers will die prematurely from tobacco-related illness. Reducing the nicotine in cigarettes to the point ...
What is the current status of trial NCT01568905?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2011-02. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01568905?
The interventions under investigation include: Low level nicotine cigarette (OTHER), Intermediate nicotine level cigarette (OTHER), High level nicotine cigarette (OTHER).
Who is sponsoring clinical trial NCT01568905?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.